Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT05866926 · TERMINATED
Trial details
- NCT number
- NCT05866926
- Sponsor
- Ferrer Internacional S.A.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2024-01-09
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.